Michael Dinerman Net Worth

What's Michael Dinerman's mailing address?

Michael's mailing address filed with the SEC is C/O VIKING THERAPEUTICS, INC., 11119 NORTH TORREY PINES ROAD, SUITE 50, SAN DIEGO, CA, 92037.

Insiders trading at Viking Therapeutics Inc

Over the last 10 years, insiders at Viking Therapeutics Inc have traded over $46,107,976 worth of Viking Therapeutics Inc stock and bought 199,715 units worth $855,627 . The most active insiders traders include Brian Lian, Charles A Jr Rowland und Marianna Mancini. On average, Viking Therapeutics Inc executives and independent directors trade stock every 75 days with the average trade being worth of $4,137,170. The most recent stock trade was executed by Brian Lian on 21 August 2024, trading 1,000 units of VKTX stock currently worth $7,770.

What does Viking Therapeutics Inc do?

novel therapeutics for metabolic and endocrine disorders.

Viking Therapeutics Inc executives and stock owners

Viking Therapeutics Inc executives and other stock owners filed with the SEC include:

• Brian Lian,
  President, Chief Executive Officer, Director
• Dr. Brian Lian Ph.D.,
  Pres, CEO & Director
• Michael Morneau,
  Vice President - Finance and Administration
• S. Kathy Rouan,
  Independent Director
• Lawson Macartney,
  Independent Chairman of the Board
• Charles Rowland,
  Independent Director
• J. Matthew Singleton,
  Independent Director
• Matthew Foehr,
  Director
• Greg Zante,
  Senior Vice President - Finance, IR Contact Officer
• Michael Morneau,
  VP of Fin. & Admin.
• Marianne Mancini,
  Chief Operating Officer
• Gregory S. Zante,
  Chief Financial Officer
• Pharmaceuticals Inc Ligand,
  10% owner
• Stephen W Webster,
  Director
• Rochelle Hanley,
  Chief Medical Officer
• Hiroko Masamune,
  Chief Development Officer
• Marianna Mancini,
  Chief Operating Officer
• Michael Dinerman,
  Chief Operating Officer